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Abstract
Objective: This systematic review and meta-analysis was performed to determine
the prevalence rate of influenza virus from different parts of Middle East region, and
present an overall relative frequency (RF) for this region.
Methods: The authors performed a systematic literature review from several reliable
databases such as PubMed, ISI Web of Science and Scopus during 2000–2016.
Furthermore, the keywords of this research were ‘Influenza’, ‘Subtype’, ‘Seropreva-
lence’, ‘Incidence’, ‘Seroepidemiology’, ‘H1N1’, ‘H3N2’, ‘H5N1’, ‘H9N2’, ‘Middle-
East’ and ‘Meta-analysis’. The reported data were selected according to inclusion and
exclusion criteria.
Results: The authors selected 71 studies out of 1147 for the present review. The
overall estimation of the prevalence of influenza virus was 10.2% [95% confidence
interval (CI): 10.1%–10.3%]. However, based on our records, the evident heterogene-
ity of influenza virus was observed among the studies (Cochran Q test, P value
<.001 and I-squared5 100%). It should be noted that influenza virus infection’s RF
varied from 0.5% in Qatar to 70% in Syria.
Conclusions: The results of this review are remarkable, they show that influenza
infection RF is variable due to several factors. Thus, further researches should be
taken to minimize the emergence and transmission of influenza virus.
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1 | INTRODUCTION AND
OBJECTIVES
Respiratory tract infections are one of the most common
acute illness which can be classified into two main types
including upper and lower respiratory tract infection (URI,
LRI), which caused by bacteria, viruses and mycobacteria.1
Influenza virus is a major cause of acute respiratory disease
in human and many animal species; so that approximately
20% of the world’s population annually are infected by influ-
enza, resulting in a significant growth in morbidity and mor-
tality.2 Influenza, a member of the Orthomyxoviridae family,
is characterized by segmented negative-sense RNA genomes.
Influenza is subdivided into three types (A, B and C) based
on antigenic differences in the virion core proteins. In addi-
tion, as far as surface glycoprotein is concerned, the virus is
classified in six genera.3,4 Generally, influenza A viruses
infect both humans and such animals as ducks, chickens,
pigs, whales, horses, seals and cats; while, influenza B
viruses circulate primarily in humans.5 Based on hemaggluti-
nin (HA) amino acid differences, influenza A is divided into
16 different HA subtypes (H1-H16), and also nine different
NA subtypes (N1-N9).6,7 The main subtypes of influenza
based on pathogenesis and epidemiology aspects include
H1N1, H5N1, H3N2, H7N7 and H9N2.8 The most symp-
toms of influenza infection can be mild to severe include
fever, sore throat, nasal discharge, myalgia, headache and
cough.9,10 Influenza has an epidemic outbreak (every 1–3
years) during the past 400 years.11 This virus is spread from
person to person mainly with respiratory droplets when
infected person coughs or sneezes.12 The documents show
that at least one pandemic influenza has occurred during the
century. Figure 1 presents the World Health Organization’s
(WHO) report about the status of the infection. It is worth
noting that the epidemiologic pattern clearly shows that mul-
tiple factors are involved in the changing of nature of the
antigenic properties of influenza viruses, and their spread
accordingly. For example, influenza A viruses, have a con-
siderable ability to undergo periodic changes in the antigenic
characteristics of their envelope glycoproteins, the hemagglu-
tinin and the neuraminidase over other types.13
Seasonal pattern of influenza is different based on tem-
perate zones: June-September in the Southern Hemisphere,
and December-April in the Northern Hemisphere. Moreover,
this pattern in tropical regions has seasonal variations and
mostly related to the rainy season.14
Although several studies have been performed on the
prevalence of influenza in Middle-East countries, there is no
overall estimation of the infection in such regions. With this
in mind, the present study aimed to systematically review the
published data about the prevalence rate of influenza from
different parts of Middle-East countries, and also the epide-
miological characteristics of influenza in this region by using
Meta-analysis.
2 | DATA SOURCE AND STUDY
SELECTION
2.1 | Search strategy
We selected several reliable databases including PubMed, ISI
Web of Science, and Scopus (up to December 2016) by using
the following keywords: ‘Influenza’, ‘Subtype’, ‘Seropreva-
lence’, ‘Incidence’, ‘Seroepidemiology’, ‘H1N1’, ‘H3N2’,
FIGURE 1 Percentage of influenza positive test based on the region inWHO report, 2016 9
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‘H5N1’, ‘H9N2’, ‘Middle-East’ and ‘Meta-analysis’. In addi-
tion to English sources, the relevant articles in two Persian
scientific search engines including ‘The Iranian Scientific
Information Database’ (www.sid.ir), and ‘Barakat Knowl-
edge Network System’ (www.barakatkns.com) were scrupu-
lously searched. Furthermore, the search by mentioned
keywords was restricted to the original articles, titles,
abstract, keywords, published abstracts in English and Per-
sian which reported the prevalence of influenza virus by
Hemagglutination Inhibition (HI), and methods based on
PCR such as RT-PCR and Multiplex RT-PCR in the Middle
East.
2.2 | Inclusion criteria
The selected references (English and Persian) in this meta-
analysis and systematic review should meet the following
criteria:
 Published between 2000 and 2016.
 All studies included samples from blood, nasal swab, throat
swab, bronchial wash, sputum and nasal or endotracheal
aspirate from patients in the Middle East.
 The reported data is a relation to a group of individuals
taken from the general population.
 Studies that used HI, ELISA, Microneutralization, Culture,
Immunochromatographic assay, Immunofluorescent assay
and PCR based methods.
2.3 | Exclusion criteria
The sources with the following criteria were removed:
 Studies published before 2000 and samples were taken
from patients outside of the Middle East with other diag-
nostic methods.
 Congress abstracts, case report articles, review articles,
studies reported in languages other than English or Persian.
 Meta-analysis or systematic reviews and duplicate publica-
tion of the same study (or published both in English and
Persian) with the exception of duplicate studied in which
most sample sizes and more detailed results were provided.
2.4 | Data collection
A complete information list was extracted from the docu-
ments, including the author’s name, publication date, sample
size, type of outbreak, type of subjects, study setting, the RF
of influenza and research location. Such details were reviewed
and confirmed by three researchers independently. Further-
more, for unclear data, the other authors were consulted and
achieved consensus before recording an entry in the dataset.
Cohen’s kappa as the agreement coefficient between the
researchers was acceptable and was equal to 0.81.
2.5 | Assessment of quality studies
Firstly, a checklist and a diagram of the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
are prepared, then the critical appraisal was applied with
Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) form. Items related to study type,
sample sizes, research objectives, population, inclusion/
exclusion criteria for primary research, a method of analysis
and appropriate presentation of results were determined;
then, a score was assigned to each item. Each question is
assigned by one score. Finally, the studies achieved at least
eight quality scores were considered eligible for final Meta-
analysis.
2.6 | Statistical methods
In this study, the number of total participants suffering influ-
enza was used to estimate the RF. For the meta-analysis, RF
was converted to log RF and its Standard Error (SE).
Additionally, we use the Freeman-Tukey Double arcsine
transformation of relative frequencies to calculate a pooled
RF.15 The heterogeneity and the variation in pooled estima-
tions were assessed using the Cochran’s Q test and I-squared,
respectively.16 The pooled RF of influenza was derived by a
random effect model, while the I2 index is more than to 50%
and otherwise this pooled prevalence was derived by a fixed
effect model. Meta-regression was used to examine the rela-
tionships between RF of influenza and year, country of pub-
lication, sample sizes and the cause of heterogeneity of
results.17 Finally, the sub-group analysis was used to avoid
the confounding the relationships between research location/
country, type of outbreak, type of subjects and the year of
publication (before 2009 vs after of 2009) with the pooled
prevalence. Moreover, a sensitivity analysis was done by
successively removing a particular study or group of studies
(if any) that had the highest impact on the heterogeneity test.
Publication bias was checked by Egger’s regression asymme-
try test and Begg’s adjusted rank correlation test18. All statis-
tical analyses were performed using STATA 11.0 (STATA
Corp, College Station, TX). A P-value less than .05 were
considered statistically significant.
3 | RESULTS
The study selection process and flowchart of the literature
search is shown in Figure 2. A total of 8983 articles reporting
influenza infection and subtypes from Middle East countries
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were found by the databases. In a primary screening process,
484 of the publications were excluded due to duplication. In
the secondary screening process, 7521 of the publications
were excluded based on title, abstract and keywords evalua-
tion and 978 articles were retained for detailed full-text eval-
uation. After evaluation of full-texts, 71 articles (abstract
with full-text articles) describing the prevalence of influenza
infection in Middle East countries were selected for the pres-
ent study and presented in Table 1. There were no confirmed
reports of some countries, including Bahrain, Cyprus, Jordan
and Palestine.
PCR based methods were the most dominant methods
used for influenza detection; some studies had also used
other more specific methods such as HI or culture. In total,
316 966 patients were analyzed for the pooled prevalence of
influenza subtypes (Table 1). The characteristics of influenza
in Middle East countries are represented in Table 2.
According to the results of the random-effects model, the
pooled prevalence of influenza was found to be 10.2% [95%
confidence interval (CI): 10.1%–10.3%]. However, the evi-
dent heterogeneity of influenza was observed among studies
(Cochran Q test, P value <.001, I25 99.9%). No publication
bias was observed in the Begg’s adjusted rank correlation
test and the Egger’s regression test (P-value5 .129; P-val-
ue5 .460, respectively). Results of meta-regression were
shown a statistically significant association between RF of
FIGURE 2 Flowchart of literature search and study selection
1790 | MOGHOOFEI ET AL.
influenza with a year of publication (b5 0.017; P-val-
ue5 .046), type of subjects (P-value5 .011) and location of
the studies (P-value5 .021). But the association between RF
of influenza with studies’ sample size and type of outbreak
was not statistically significant (b<21.2 3 1026; P-val-
ue5 .251), (P-value5 .346), respectively. According to the
sub-group analysis, the prevalence of influenza in Middle
East countries was increased over year of publication (Figure
3), highest and lowest prevalence of influenza were related
to Syria (70%; 95% CI: 60%–80%) and Qatar (0.5%; 95% CI:
0.1%–0.9%), respectively. According to the type of subjects,
highest and lowest prevalence of influenza were related to
pregnant women (29.6%; 95% CI: 20.7%–38.5%) and Haj
Pilgrims (2.6%; 95% CI: 2.3%–3%). More details are shown
in Table 3 and the Figures 4 and 5. Sensitivity analysis was
performed by sequential omission of individual and group of
studies. The combined RFs of the prevalence rate of influ-
enza from sequential omission was not altered after omission
(13.2%; 95% CI: 9.2%–17.2%), indicating that our results
were statistically robust.
4 | DISCUSSION
Respiratory viral infection is very important in public health
due to its ability to spread easily. So, influenza as one of
these infections affects up to 5%-10% of the world’s popu-
lation annually.89 The importance of influenza is increasing
mainly because of the appearance of novel pandemic strains
in swine and avian. Each year, influenza has spread around
the world and causing about 250 000–500 000 deaths and
more than 5 million cases of severe illness.9 As mentioned
in the previous part, this systematic review and meta-
analysis are performed to estimate the prevalence of influ-
enza infection in the Middle East. The authors of this study
conducted a comprehensive search of 71 studies from 17
countries to presents the available epidemiological charac-
teristics of influenza infection between 2000 and 2016. In
this study, the pooled estimation of the influenza prevalence
was 10.2%. The results of the current study revealed that
the prevalence of influenza infection in the Middle East
and the study population is variable. A multitude of factors
such as population density, population movement, aging
population, vaccination, herd immunity, geographical
region, seasonality effects, etc., could be the effect on this
variability.90 In this systematic review, the most common
influenza subtype was H1N1. The prevalence of H3N2 was
reported in different parts of the world as follow: Thailand
(18%), northern Iran (35.2%), National Influenza Centers
(NICs) and other national influenza laboratories from 91
countries (92.5% during 06 February 2017 to 19 February
2017).79,91 H5N1 is a highly infectious type of influenza
virus that causes severe respiratory disease. Person to per-
son transmission of this virus is difficult, although several
outbreaks of the virus in humans were reported. The mor-
tality rate of H5N1 is about 60%.92 Prevalence of H5N1
has reported 856 cases during 2003–2017 and 452 of them
was dead.93
Children, healthcare worker (HCW), pregnant women,
Hajj pilgrim, poultry worker and the general population were
included in this study. HCWs are the most vulnerable group
because of close contact with patients. In the current study,
pooled prevalence for HCWs was 5.5%. In an investigation,
Kuster et al reported incidence rates of influenza in vacci-
nated and unvaccinated HCWs were 6.5% and 18.7%,
respectively.94 Children have the highest rate of influenza
infection which led to hospitalization.95 The prevalence of
influenza in children was reported 9.7%–29.0% based on the
region by US influenza Surveillance Report.96 Also, in our
study prevalence of influenzas in children was, 29.4% and
24.6%. Pregnant women are another high-risk group for
influenza because the disease could be severe. In this meta-
analysis prevalence of influenza in pregnant women was the
highest rate, 29.6%. Previous studies have shown that these
group of patients are associated with about 6% of influenza-
related hospitalization.97 One of the most common infections
TABLE 1 Studies’ characteristics
Subjects Number of studies Total of sample size Total of cases Types of influenza virus
Children 12 4964 1455 H1N1, H3N2
Pregnant women 2 98 29 H1N1
Poultry worker 2 196 34 H9N2
Haj pilgrims 10 7476 195 H1N1, H3N2
Healthcare workers 2 9801 538 H1N1
General population 43 293 831 29 391 H1N1, H3N2, H5N1
Total 71 316 966 31 642 4 types
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transmitted between pilgrims is viral respiratory infections,
especially influenza.98 In our study, the prevalence of influ-
enza was 2.6%, whereas the prevalence of this virus in Hajj
pilgrims were 93.4%, 90.7%, 97.0% in Malaysia (2013,
2012, 2009, respectively), 77.6% in Africa, 90.0% in Saudi
Arabia based on previous investigations.99 This difference
can be due to several reasons such as vaccination, public
health level, nutritional status, etc. Poultry workers are
another group which studied in our investigations, with
17.3% prevalence of influenza. Pawar et al reported the prev-
alence of H9N2 in poultry workers 4.7% and 3.8% by HI and
MN assay, respectively. H9N2 usually led to mild symptoms
in humans and on the other hand easy to distinguish H9N2
symptoms with H3N2, H1N1; therefore, the accurate preva-
lence rate is not available.100
FIGURE 3 The prevalence of influenza diagram inMiddle East
countries over time
TABLE 3 Subgroup analysis for the type of outbreak, type of subjects, area and year of publication
Characteristics Categories
No.
of studies
Pooled
prevalence
(95% C.I)
Heterogeneity test
(I2%, P-value)
Publication bias
(Begg’s test,
P-value; Egger’s test, P-value)
All Studies – 71 0.102 (0.101–0.103) (100%; P-value <.001) (Begg’s test, .129; Egger’s test, .46)
Type of outbreak Pandemic 38 0.100 (0.099–0.101) (100%; P-value <.001) (Begg’s test, .066; Egger’s test, .001)
Seasonal 24 0.110 (0.107–0.114) (99.5%; P-value <.001) (Begg’s test, .637; Egger’s test, .010)
Type of subjects General
population
42 0.103 (0.102–0.103) (100%; P-value <.001) (Begg’s test, .013; Egger’s test, .001)
Children
(<6 years old)
5 0.294 (0.279–0.309) (99.8%; P-value <.001) (Begg’s test, .806; Egger’s test, .276)
Children
(<18 years old)
7 0.246 (0.229–0.262) (99.5%; P-value <.001) (Begg’s test, .072; Egger’s test, .113)
Haj Pilgrims 10 0.026 (0.023–0.030) (98.6%; P-value <.001) (Begg’s test, .210; Egger’s test, .011)
Healthcare workers 2 0.055 (0.050–0.059) (95.7%; P-value <.001) (Begg’s test, NA; Egger’s test, NA)
Poultry worker 2 0.173 (0.120–0.226) (0.0%; P-value 5.896) (Begg’s test, NA; Egger’s test, NA)
Pregnant women 2 0.296 (0.207–0.385) (78.8%; P-value 5.030) (Begg’s test, NA; Egger’s test, NA)
Year of publication 2008 8 0.099 (0.086–0.112) (95.4%; P-value <.001) (Begg’s test, .063; Egger’s test, .158)
>2008 63 0.102 (0.101–0.103) (100%; P-value <.001) (Begg’s test, .102; Egger’s test, .55)
Area Iran 24 0.185 (0.182–0.188) (99.5%; P-value <.001) Begg’s test, .021; Egger’s test, <.001)
Egypt 8 0.077 (0.073–0.081) (99.8%; P-value <.001) Begg’s test, .63; Egger’s test, .85)
Saudi Arabia 9 0.009 (0.008–0.009) (99.7%; P-value <.001) Begg’s test, .251; Egger’s test, .162)
Pakistan 4 0.159 (0.147–0.171) (99.4%; P-value <.001) Begg’s test, .734; Egger’s test, .81)
Oman 4 0.315 (0.304–0.326) (99.2%; P-value <.001) Begg’s test, .31; Egger’s test, .16)
Iraq 2 0.30 (0.284–0.316) (0%; P-value <.623) Begg’s test, NA; Egger’s test, NA)
Turkey 12 0.346 (0.341–0.351) (99.9%; P-value <.001) Begg’s test, .15; Egger’s test, .01)
Israel 2 0.345 (0.332–0.357) (97.8%; P-value <.001) Begg’s test, NA; Egger’s test, NA)
Lebanon 2 0.08 (0.067–0.093) (88.1%; P-value 5.004) Begg’s test, NA; Egger’s test, NA)
Kuwait 1 0.32 (0.254–0.385) NA Begg’s test, NA; Egger’s test, NA)
Qatar 1 0.005 (0.001–0.009) NA Begg’s test, NA; Egger’s test, NA)
Syria 1 0.70(0.60–0.80) NA Begg’s test, NA; Egger’s test, NA)
United
Arab Emirates
1 0.333 (0.315–0.350) NA Begg’s test, NA; Egger’s test, NA)
NA: Not applicable.
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The time of occurrence outbreaks of influenza virus is
different in several parts of the earth. For instance, in the
Northern Hemisphere, it occurs between November and
March; However, in the Southern Hemisphere, flu occurs
between April and September; moreover, in the temperate
and tropical zones, it occurs in winter and throughout the
year, respectively.101
In this study, we demonstrated that most of the outbreaks
of influenza were pandemic related to H1N1. Similar to our
results, several investigations have shown that influenza A
virus, especially H1N1, pdm09 and H3N2 were circulating
subtypes in Iran, Afghanistan, Egypt and Yemen. Such sub-
types were associated with increased hospitalization and
death.102 In another investigation, Nielsen et al reported
influenza that the viruses subtype in clinical samples during
1994–2010 as follows: A/H3N2 seasonal during 1995–1999,
2005–2006 and A/H1N1 pandemic in 2009.103 H1N1 was
first reported in Mexico in 2009 and lead to 12 470 deaths
and 274 000 hospitalizations in 2009–2010.45 The highest
mortality rate of H1N1 was reported in Damascus (51%),
Mexico (41.4%) and Iran.104,105
The first human infections caused by H9N2 was reported
in 1999, Hong Kong. Prevalence of H9N2 in Iran was
reported 17%-18%.69,88 These subtypes have repeatedly been
isolated from patients in China and Hong Kong.106 Khan
et al reported that the seroprevalence of H9N2 ranged from
1% to 43%. Their results were based on HI methods and sim-
ilar to WHO report.107 One of the important limitation of
Khan’s investigation is that the immune responses of human
against infections with avian viruses are poor. Badar et al in
Pakistan tested 6258 specimens and showed that 72% of
them were positive for influenza A viruses. Also, they dem-
onstrated that the prevalence of subtype as following: 82%
were H1N1 pdm09, 16% H3N2 and 2% seasonal A/H1N1.14
It has been reported that 18% of clinical samples from
patients were isolated human influenza viruses in Thailand
(2004–2006).79 Prevalence of influenza among Australian
hospitals reported by Blyth et al. They detected influenza A
in 90% of 402 patients. Among the positive samples, H1N1,
pdm09 and H3N2 were confirmed as a most frequent sub-
type.95 Epidemiological studies can be used for several pur-
poses such as identify the dominant types of the virus to
vaccination strategies for population and subgroups, identify
high-risk groups and identification of the epidemiological
pattern of the disease.
5 | CONCLUSION
The current study provides the overall influenza prevalence
rate and information about circulating types of influenza virus
in different geographical areas of Middle-East. The outbreak
FIGURE 4 Forest plot is showing influenza infection prevalence estimates of patients in Iran, Iraq, Lebanon and Egypt
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is obtained will constantly increase over the next years.
However, it should be noted that our results may be affected
by several factors due to insufficient data on Middle
East countries resulted from a small number of surveys, and
low or inadequate geographical coverage of the studies. So,
a comprehensive future population-based study is highly
recommended to investigate the effects of all variable
parameters.
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